Keratin 17 mutation in pachyonychia congenita type 2 with early onset sebaceous cysts

British Journal of Dermatology

Volumn 148, Issue 3, 2003, Pages 452-455

  Feng, Y G ^a   Xiao, Sheng Xiang ^a   Ren, X R ^a   Wang, W Q ^b   Liu, A ^a   Pan, M ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NONE

Author keywords

Ectodermal dysplasia; Genodermatosis; Intermediate filaments; Nail dystrophy; Pachyonychia congenita

Indexed keywords

ASPARAGINE; GENOMIC DNA; KERATIN; SERINE;

ARTICLE; CLINICAL STUDY; CODON; CONGENITAL PACHYONYCHIA; EXON; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; MUTATION; NAIL DISEASE; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SEBACEOUS CYST; SEQUENCE ANALYSIS;

ADOLESCENT; AGE OF ONSET; CHINA; ECTODERMAL DYSPLASIA; EPIDERMAL CYST; FEMALE; HUMANS; INFANT; KERATINS; MALE; MUTATION; NAILS, MALFORMED; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; SKIN DISEASES;

EID: 0037362490     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05152.x     Document Type: Article

References (22)

1. Lane EB. Keratins. In: Connective Tissue and its Heritable Disorders. Molecular, Genetic, and Medical Aspects (Royce PM. Steinmann B, eds). New York: Wiley-Liss, 1993: 237-47.
2. Letai A, Coulombe PA, Fuchs E. Do the ends justify the means? Proline mutations at the ends of the keratin coiled-coil rod segment are more disruptive than internal mutations. J Cell Biol 1992: 116: 1181-95.
3. Lane EB. Keratin diseases. Curr Opin Gen Dev 1994; 4: 412-18.
4. Fuchs E, Weber K. Intermediate filaments, structure, dynamics, function and disease. Annu Rev Biochem 1994; 63: 345-82.
5. Corden LD. McLean WHI. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol 1996; 5: 297-307.
6. Stratigos AJ, Baden HP, Unraveling the molecular mechanisms of hair and nail genodermatoses. Arch Dermatol 2001; 137: 1465-71.
7. Gorlin RJ, Pindborg JJ, Cohen MM Jr. Syndromes of the Head and Neck, New York: McGraw-Hill, 1976.
8. Bowden PE, Haley JL, Kansky A et al. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat Genet 1995; 10: 363-5.
9. Smith FJD, McKenna KE, Irvine AD et al. A mutation detection strategy for the human keratin 6A gene and novel mutations in two cases of pachyonychia congenita type 1. Exp Dermatol 1999; 8: 109-14.
10. McLean WHI, Rugg EL, Lunny DP et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet 1995; 9: 273-6.
11. Smith FJD, Fisher MP, Healy E et al. Novel keratin 16 mutations and protein expression studies in pachyonychia congenita type 1 and focal palmoplantar keratoderma. Exp Dermatol 2000; 9: 170-7.
12. Smith FJD, van Jonkman MF, Goor H et al. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet 1998; 7: 1143-8.
13. Covello SP, Smith FJD, Smitt HSS et al. Keratin 17 mutations cause pachyonychia congenita type 2 or steatocystoma multiplex. Br J Dermatol 1998; 139: 475-80.
14. Smith FJD, Corden LD, Rugg EL et al. Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997; 108: 220-3.
15. Pallet AS, Moore JA, Scher R. Pachyonychia congenita tarda. A late-onset form of pachyonychia congenita. Arch Dermatol 1991; 127: 701-3.
16. Hashiguchi T, Yotsumoto S, Shimada H et al. A novel point mutation in the keratin 17 gene in a Japanese case of pachyonychia congenita type 2. J Invest Dermatol 2002; 118: 545-7.
17. Celebi JT, Tanzi EL, Yao YJ et al. Mutation report: identification of a germline mutation in keratin 17 in a family with pachyonychia congenita type 2. J Invest Dermatol 1999; 113: 848-50.
18. Smith FJD, Coleman CM, Bayoumy NM et al. Novel keratin 17 mutations in pachyonychia congenita type 2. J Invest Dermatol 2001; 116: 806-8.
19. Terrinoni A, Smith FJD, Didona B et al. Novel and recurrent mutation in the genes encoding keratin K6a, K16 and K17 in 13 cases of pachyonychia congenita. J Invest Dermatol 2001; 117: 1391-6.
20. Connors JB, Rahil AK, Smith FJD et al. Delayed onset pachyonychia congenita associated with a novel mutation in the central 2B domain of keratin 16. Br J Dermatol 2000; 41: 175-7.
21. Munro CS. Pachyonychia congenita, mutation and clinical presentations. Br J Dermatol 2001; 144: 929-30.
22. Irvine AD, McLean WHI. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999; 140: 815-28.